ReviewRSC advances2026

Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives.

Hamada S AbulkhairPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.